Senate, October 9, 2025 -- The committee on Senate Ways and Means, to whom was referred the Senate Bill relative to menstrual product ingredient disclosure (Senate, No. 1483),- reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 2641).